April 21, 2003
FOR IMMEDIATE RELEASE
Information: Contact Gus Ostrum at (856) 256-2306
Charlotte Szromba, Christy Price, and Mary Schira Appointed to the Nephrology Nursing Journal Editorial Board
PITMAN, NJ Charlotte Szromba, MSN, RN, NP, CS, CNN, of Chicago, Illinois; Christy Price, NP, of Salt Lake City, Utah; and Mary Schira, PhD, RN, CS, ACNP, of Arlington, Texas, have been appointed to the Nephrology Nursing Journal Editorial Board, effective immediately.
Ms. Szromba is a nurse practitioner in the Section of Nephrology at the University of Chicago. She also serves as the Distance Learning Chairperson for the American Nephrology Nurses Association (ANNA). In addition, she has held numerous volunteer positions within ANNA.
Ms. Price is employed with Nephrology Associates in Salt Lake City. She has served in numerous positions within ANNA, including Past President, and is currently an Ad Hoc Advanced Practice SIG Member. She is also a past member of the Nephrology Nursing Journal Editorial Board.
Ms. Schira is the Associate Clinical Professor and Director of the ACNP Program at the University of Texas at Arlington School of Nursing. In addition to numerous volunteer positions within ANNA, she currently serves as the Conference Planning Committee Chairperson.
"Charlotte, Christy, and Mary are valuable additions to our Editorial Board", commented Editor Beth Ulrich, EdD, RN, CHE. Each is well respected within ANNA for her many past contributions, and brings valuable expertise in the area of nephrology nursing to our journal.
Nephrology Nursing Journal is a refereed clinical and scientific resource that provides current information on a wide variety of subjects to facilitate the practice of professional nephrology nursing. Nephrology Nursing Journal is the official publication of ANNA.
ANNA is a professional nursing association composed of more than 12,000 nephrology nurses. The association is dedicated to advancing nephrology nursing practice and positively influencing outcomes for patients with kidney or other disease processes requiring replacement therapies through advocacy, scholarship, and excellence.
# # #